Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Olaparib In Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03344965
Recruitment Status : Recruiting
First Posted : November 17, 2017
Last Update Posted : August 12, 2020
Sponsor:
Collaborators:
Johns Hopkins University
AstraZeneca
Information provided by (Responsible Party):
Nadine Tung, MD, Beth Israel Deaconess Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 30, 2020
Estimated Study Completion Date : December 30, 2021